Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lév. Thetsrimuang C, Khammuang S, Chiablaem K, Srisomsap C, Sarnthima R*. Food Chem. 2011 Oct 1;128(3):634-39.

01 Oct 2011
0
0

Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lév.

Thetsrimuang C, Khammuang S, Chiablaem K, Srisomsap C, Sarnthima R*.

Food Chem. 2011 Oct 1;128(3):634-39.

Tags

Share this

Related Posts

Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J, Sangvanich P*. Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):229-37.
01 Jul 2009
0

Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J, Sangvanich P*. Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):229-37.

Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J, Sangvanich P*. Cancer Genomics Proteomics. 2009 Jul-Aug;6(4):229-37.
View More
Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells. Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K. Vasc Med. 2018 Jun;23(3):201-211.
01 Jun 2018
0

Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells. Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L, Svasti J, Koizumi K. Vasc Med. 2018 Jun;23(3):201-211.

Aspirin suppresses components of lymphangiogenesis and lymphatic vessel remodeling by inhibiting the NF-κB/VCAM-1 pathway in human lymphatic endothelial cells. Prangsaengtong O*, Jantaree P, Lirdprapamongkol K, Ngiwsara L,Svasti J, Koizumi K. Vasc Med. 2018 Jun;23(3):201-211.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More